Virtual drug discovery and development for neglected diseases through public–private partnerships
- 1 November 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 2 (11), 919-928
- https://doi.org/10.1038/nrd1230
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Stimulating pharmaceutical research and development for neglected diseasesHealth Policy, 2002
- Strategic emphases for tropical diseases research: a TDR perspectiveTrends in Parasitology, 2002
- Two decades of orphan product developmentNature Reviews Drug Discovery, 2002
- Drug development for neglected diseases: a deficient market and a public-health policy failureThe Lancet, 2002
- Public sector must develop drugs for neglected diseasesBMJ, 2002
- Drugs for neglected diseases: a failure of the market and a public health failure?Tropical Medicine & International Health, 2001
- Current issues in the treatment of visceral leishmaniasisMedical Microbiology and Immunology, 2001
- Editorial: Drugs for 'neglected diseases': a bitter pillTropical Medicine & International Health, 2000
- Modern medicine and global communicable diseases: new partnerships for progressAustralian and New Zealand Journal of Medicine, 2000
- The Global Drug GapScience, 2000